Physician profile
Oliver F Adunka
NPI 1316975444
$337,879.19
in general payments reported to CMS, 2019-2025
5 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138K · 2020: $138 · 2021: $423 · 2022: $63K · 2023: $56K · 2024: $23K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $112K · Travel and Lodging: $20K · Food and Beverage: $2,673 · Consulting Fee: $1,060 · Education: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $111,896.50 |
| Travel and Lodging | $20,418.55 |
| Food and Beverage | $2,672.97 |
| Consulting Fee | $1,060.00 |
| Education | $837.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Bionics, LLC | $311,575.11 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Med-El Corporation | $23,941.18 | 2019-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Americas | $2,011.45 | 2021-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Iotamotion, INC. | $182.69 | 2023-2025 | Iotasoft, Iotasoft Insertion System |
| Medtronic, INC. | $168.76 | 2023 | Nim Vital, Nim-Response |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Adunka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.